Top news of the week: 23.12.2022.
Can COVID-19 Reboot Drug Repurposing?
It seems like a slam dunk. Why not repurpose already approved or well-studied drug candidates for conditions where treatments are desperately needed? Wouldn’t that be an easy way to speed ...
Pfizer Doubles Down on AI/ML to Bring Transformative Medicines to Patients
Pfizer is rapidly scaling up its AI/ML efforts in a collaborative effort intended to get transformative medicines to patients faster.
It’s a New Day in Neuropsychiatrics
The forecast of psychedelic and psychedelic-assisted therapies in the neuropsychiatric space has been cloudy and overcast for decades.
9 biotechnology gifts to get these holidays
If you're looking for biotechnology gifts for your friends, look no further: • 3D models • biology-themed notebooks • DIY biology kits
FDA approves Ferring's new gene therapy for bladder cancer
Following a CRL in May 2021 due to CMC issues, the FDA this afternoon announced the approval of Ferring's adenoviral vector-based gene therapy Adstiladrin (nadofaragene firadenovec-vncg) ...
InSitu Biologics and Mayo Clinic to co-develop anti-cancer therapeutics
InSitu Biologics and the Mayo Foundation for Medical Education and Research are to co-develop prolonged-release drug delivery technology.
Taysha CEO steps down after patent fights with patient families, job cuts
Taysha Gene Therapies CEO RA Session II has resigned following a turbulent year in which the company shelved most of its rare disease pipeline and faced criticism from families for blocking ...
Ori Biotech and Inceptor Bio partner on solid tumor cell therapy
Cell and gene therapy company Ori Biotech, and cell therapy firm Inceptor Bio have announced a new partnership.